게놈 연구 및 분석용 FFPE 조직 샘플 시장 : 조직 샘플 유형 : 용도 - 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

FFPE Tissue Samples For Genomics Study And Analysis Market - Scope of Report

TMR's report on the global FFPE tissue samples for genomics study and analysis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global FFPE tissue samples for genomics study and analysis market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global FFPE tissue samples for genomics study and analysis market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the FFPE tissue samples for genomics study and analysis market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global FFPE tissue samples for genomics study and analysis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global FFPE tissue samples for genomics study and analysis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global FFPE tissue samples for genomics study and analysis market.

The report delves into the competitive landscape of the global FFPE tissue samples for genomics study and analysis market. Key players operating in the global FFPE tissue samples for genomics study and analysis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global FFPE tissue samples for genomics study and analysis market profiled in this report.

Key Questions Answered in Global FFPE tissue samples for genomics study and analysis Market Report:

• What is the sales/revenue generated by FFPE tissue samples for genomics study and analysis across all regions during the forecast period?
• What are the opportunities in the global FFPE tissue samples for genomics study and analysis market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

FFPE Tissue Samples For Genomics Study And Analysis Market - Research Objectives and Research Approach

The comprehensive report on the global FFPE tissue samples for genomics study and analysis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global FFPE tissue samples for genomics study and analysis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global FFPE tissue samples for genomics study and analysis market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global FFPE Tissue Samples For Genomics Study & Analysis Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecasts, 2020-2034
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Overview: Future of FFPE Tissue Samples For Genomics Study & Analysis in Personalized Healthcare
• 5.2. Summary of Quality Control Metrics for FFPE-NT DNA Sections
• 5.3. Information of Samples Subjected to Single-Cell Sequencing
• 5.4. Application of FFPE Tissue Samples For Genomics Study & Analysis in Genomics Study
• 5.5. Healthcare Industry Overview
• 5.6. Key Industry Events
• 5.7. PESTEL Analysis
• 5.8. PORTER's Five Forces Analysis
• 5.9. Regulatory Scenario by Key Countries/Regions
• 5.10. Pricing Trends
• 5.11. Supply Chain Analysis
• 5.12. Unmet Needs of the Market
• 5.13. Incidence and Prevalence of Diseases
• 5.14. Recommendations and Analyst View on Investments in FFPE Tissue Samples For Genomics Study & Analysis in Genomics

6. Global FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecasts, By Product

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product, 2020-2034
  • 6.3.1. FFPE Sections
  • 6.3.2. FFPE Arrays
  • 6.3.3. FFPE Panels
  • 6.3.4. FFPE Blocks
• 6.4. Market Attractiveness By Product

7. Global FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecasts, By Tissue Sample Type

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Tissue Sample Type, 2020-2034
  • 7.3.1. FFPE Normal Tissue Samples
  • 7.3.2. FFPE Diseased Tissue Samples
• 7.4. Market Attractiveness By Tissue Sample Type

8. Global FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecasts, By Application

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Application, 2020-2034
  • 8.3.1. DNA Extraction
  • 8.3.2. RNA Extraction
  • 8.3.3. Next-Generation Sequencing (NGS)
  • 8.3.4. PCR and qPCR
  • 8.3.5. Microarray Analysis
  • 8.3.6. DNA Methylation Studies
  • 8.3.7. Others (Single Cell Genomics, etc.)
• 8.4. Market Attractiveness By Application

9. Global FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecasts, By End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By End-user, 2020-2034
  • 9.3.1. Hospitals & Diagnostic Laboratories
  • 9.3.2. Pharmaceutical & Biotechnology Companies
  • 9.3.3. Research & Scientific Laboratories
  • 9.3.4. Others
• 9.4. Market Attractiveness By End-user

10. Global FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Region

11. North America FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Product, 2020-2034
  • 11.2.1. FFPE Sections
  • 11.2.2. FFPE Arrays
  • 11.2.3. FFPE Panels
  • 11.2.4. FFPE Blocks
• 11.3. Market Value Forecast By Tissue Sample Type, 2020-2034
  • 11.3.1. FFPE Normal Tissue Samples
  • 11.3.2. FFPE Diseased Tissue Samples
• 11.4. Market Value Forecast By Application, 2020-2034
  • 11.4.1. DNA Extraction
  • 11.4.2. RNA Extraction
  • 11.4.3. Next-Generation Sequencing (NGS)
  • 11.4.4. PCR and qPCR
  • 11.4.5. Microarray Analysis
  • 11.4.6. DNA Methylation Studies
  • 11.4.7. Others (Single Cell Genomics, etc.)
• 11.5. Market Value Forecast By End-user, 2020-2034
  • 11.5.1. Hospitals & Diagnostic Laboratories
  • 11.5.2. Pharmaceutical & Biotechnology Companies
  • 11.5.3. Research & Scientific Laboratories
  • 11.5.4. Others
• 11.6. Market Value Forecast By Country, 2020-2034
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product
  • 11.7.2. By Tissue Sample Type
  • 11.7.3. By Application
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product, 2020-2034
  • 12.2.1. FFPE Sections
  • 12.2.2. FFPE Arrays
  • 12.2.3. FFPE Panels
  • 12.2.4. FFPE Blocks
• 12.3. Market Value Forecast By Tissue Sample Type, 2020-2034
  • 12.3.1. FFPE Normal Tissue Samples
  • 12.3.2. FFPE Diseased Tissue Samples
• 12.4. Market Value Forecast By Application, 2020-2034
  • 12.4.1. DNA Extraction
  • 12.4.2. RNA Extraction
  • 12.4.3. Next-Generation Sequencing (NGS)
  • 12.4.4. PCR and qPCR
  • 12.4.5. Microarray Analysis
  • 12.4.6. DNA Methylation Studies
  • 12.4.7. Others (Single Cell Genomics, etc.)
• 12.5. Market Value Forecast By End-user, 2020-2034
  • 12.5.1. Hospitals & Diagnostic Laboratories
  • 12.5.2. Pharmaceutical & Biotechnology Companies
  • 12.5.3. Research & Scientific Laboratories
  • 12.5.4. Others
• 12.6. Market Value Forecast By Country, 2020-2034
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Spain
  • 12.6.5. Italy
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product
  • 12.7.2. By Tissue Sample Type
  • 12.7.3. By Application
  • 12.7.4. By End-user
  • 12.7.5. By Country/sub-region

13. Asia Pacific FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product, 2020-2034
  • 13.2.1. FFPE Sections
  • 13.2.2. FFPE Arrays
  • 13.2.3. FFPE Panels
  • 13.2.4. FFPE Blocks
• 13.3. Market Value Forecast By Tissue Sample Type, 2020-2034
  • 13.3.1. FFPE Normal Tissue Samples
  • 13.3.2. FFPE Diseased Tissue Samples
• 13.4. Market Value Forecast By Application, 2020-2034
  • 13.4.1. DNA Extraction
  • 13.4.2. RNA Extraction
  • 13.4.3. Next-Generation Sequencing (NGS)
  • 13.4.4. PCR and qPCR
  • 13.4.5. Microarray Analysis
  • 13.4.6. DNA Methylation Studies
  • 13.4.7. Others (Single Cell Genomics, etc.)
• 13.5. Market Value Forecast By End-user, 2020-2034
  • 13.5.1. Hospitals & Diagnostic Laboratories
  • 13.5.2. Pharmaceutical & Biotechnology Companies
  • 13.5.3. Research & Scientific Laboratories
  • 13.5.4. Others
• 13.6. Market Value Forecast By Country, 2020-2034
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product
  • 13.7.2. By Tissue Sample Type
  • 13.7.3. By Application
  • 13.7.4. By End-user
  • 13.7.5. By Country/sub-region

14. Latin America FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product, 2020-2034
  • 14.2.1. FFPE Sections
  • 14.2.2. FFPE Arrays
  • 14.2.3. FFPE Panels
  • 14.2.4. FFPE Blocks
• 14.3. Market Value Forecast By Tissue Sample Type, 2020-2034
  • 14.3.1. FFPE Normal Tissue Samples
  • 14.3.2. FFPE Diseased Tissue Samples
• 14.4. Market Value Forecast By Application, 2020-2034
  • 14.4.1. DNA Extraction
  • 14.4.2. RNA Extraction
  • 14.4.3. Next-Generation Sequencing (NGS)
  • 14.4.4. PCR and qPCR
  • 14.4.5. Microarray Analysis
  • 14.4.6. DNA Methylation Studies
  • 14.4.7. Others (Single Cell Genomics, etc.)
• 14.5. Market Value Forecast By End-user, 2020-2034
  • 14.5.1. Hospitals & Diagnostic Laboratories
  • 14.5.2. Pharmaceutical & Biotechnology Companies
  • 14.5.3. Research & Scientific Laboratories
  • 14.5.4. Others
• 14.6. Market Value Forecast By Country, 2020-2034
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product
  • 14.7.2. By Tissue Sample Type
  • 14.7.3. By Application
  • 14.7.4. By End-user
  • 14.7.5. By Country/sub-region

15. Middle East & Africa FFPE Tissue Samples For Genomics Study & Analysis Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Product, 2020-2034
  • 15.2.1. FFPE Sections
  • 15.2.2. FFPE Arrays
  • 15.2.3. FFPE Panels
  • 15.2.4. FFPE Blocks
• 15.3. Market Value Forecast By Tissue Sample Type, 2020-2034
  • 15.3.1. FFPE Normal Tissue Samples
  • 15.3.2. FFPE Diseased Tissue Samples
• 15.4. Market Value Forecast By Application, 2020-2034
  • 15.4.1. DNA Extraction
  • 15.4.2. RNA Extraction
  • 15.4.3. Next-Generation Sequencing (NGS)
  • 15.4.4. PCR and qPCR
  • 15.4.5. Microarray Analysis
  • 15.4.6. DNA Methylation Studies
  • 15.4.7. Others (Single Cell Genomics, etc.)
• 15.5. Market Value Forecast By End-user, 2020-2034
  • 15.5.1. Hospitals & Diagnostic Laboratories
  • 15.5.2. Pharmaceutical & Biotechnology Companies
  • 15.5.3. Research & Scientific Laboratories
  • 15.5.4. Others
• 15.6. Market Value Forecast By Country, 2020-2034
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product
  • 15.7.2. By Tissue Sample Type
  • 15.7.3. By Application
  • 15.7.4. By End-user
  • 15.7.5. By Country/sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis, by Company (2023)
• 16.3. Company Profiles
  • 16.3.1. BioChain Institute, Inc.
    • 16.3.1.1. Company Overview
    • 16.3.1.2. Financial Overview
    • 16.3.1.3. Product Portfolio
    • 16.3.1.4. Business Strategies
    • 16.3.1.5. Recent Developments
  • 16.3.2. Amsbio
    • 16.3.2.1. Company Overview
    • 16.3.2.2. Financial Overview
    • 16.3.2.3. Product Portfolio
    • 16.3.2.4. Business Strategies
    • 16.3.2.5. Recent Developments
  • 16.3.3. Cureline
    • 16.3.3.1. Company Overview
    • 16.3.3.2. Financial Overview
    • 16.3.3.3. Product Portfolio
    • 16.3.3.4. Business Strategies
    • 16.3.3.5. Recent Developments
  • 16.3.4. Discovery Life Sciences
    • 16.3.4.1. Company Overview
    • 16.3.4.2. Financial Overview
    • 16.3.4.3. Product Portfolio
    • 16.3.4.4. Business Strategies
    • 16.3.4.5. Recent Developments
  • 16.3.5. QIAGEN
    • 16.3.5.1. Company Overview
    • 16.3.5.2. Financial Overview
    • 16.3.5.3. Product Portfolio
    • 16.3.5.4. Business Strategies
    • 16.3.5.5. Recent Developments
  • 16.3.6. Thermo Fischer Scientific, Inc.
    • 16.3.6.1. Company Overview
    • 16.3.6.2. Financial Overview
    • 16.3.6.3. Product Portfolio
    • 16.3.6.4. Business Strategies
    • 16.3.6.5. Recent Developments
  • 16.3.7. Merck kGaA
    • 16.3.7.1. Company Overview
    • 16.3.7.2. Financial Overview
    • 16.3.7.3. Product Portfolio
    • 16.3.7.4. Business Strategies
    • 16.3.7.5. Recent Developments
  • 16.3.8. OriGene Technologies.
    • 16.3.8.1. Company Overview
    • 16.3.8.2. Financial Overview
    • 16.3.8.3. Product Portfolio
    • 16.3.8.4. Business Strategies
    • 16.3.8.5. Recent Developments
  • 16.3.9. BioIVT
    • 16.3.9.1. Company Overview
    • 16.3.9.2. Financial Overview
    • 16.3.9.3. Product Portfolio
    • 16.3.9.4. Business Strategies
    • 16.3.9.5. Recent Developments
  • 16.3.10. Genoskin
    • 16.3.10.1. Company Overview
    • 16.3.10.2. Financial Overview
    • 16.3.10.3. Product Portfolio
    • 16.3.10.4. Business Strategies
    • 16.3.10.5. Recent Developments
  • 16.3.11. TriStar Technology Group LLC
    • 16.3.11.1. Company Overview
    • 16.3.11.2. Financial Overview
    • 16.3.11.3. Product Portfolio
    • 16.3.11.4. Business Strategies
    • 16.3.11.5. Recent Developments
  • 16.3.12. LifeNet Health Lifesciences
    • 16.3.12.1. Company Overview
    • 16.3.12.2. Financial Overview
    • 16.3.12.3. Product Portfolio
    • 16.3.12.4. Business Strategies
    • 16.3.12.5. Recent Developments
  • 16.3.13. Samplesmart Inc.
    • 16.3.13.1. Company Overview
    • 16.3.13.2. Financial Overview
    • 16.3.13.3. Product Portfolio
    • 16.3.13.4. Business Strategies
    • 16.3.13.5. Recent Developments
  • 16.3.14. Audubon Bioscience
    • 16.3.14.1. Company Overview
    • 16.3.14.2. Financial Overview
    • 16.3.14.3. Product Portfolio
    • 16.3.14.4. Business Strategies
    • 16.3.14.5. Recent Developments